-
FDA clears narrow use of Lynparza in early prostate cancer — AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral --FDA approves Pfizer’s RSV vaccine for older adults -- See more on our front page news http://bit.ly/w28kSd See more on our front page newsDismiss Notice
Create Thread
A moderated forum to discuss general whistleblower/fraud issues with attorneys specializing in this area.